Vocabria and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Vocabria (cabotegravir sodium), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Edurant, and have Hiv infection.

The phase IV clinical study analyzes which people have Rashes when taking Vocabria. It is created by eHealthMe based on reports of 977 people who have side effects when taking Vocabria from the FDA, and is updated regularly.

What is Vocabria?

Vocabria has active ingredients of cabotegravir sodium. eHealthMe is studying from 977 Vocabria users. Check the latest studies of Vocabria.

What is Rashes?

Rashes (redness) is found to be associated with 3,712 drugs and 6,212 conditions by eHealthMe. Check the latest studies of Rashes.

On Jul, 06, 2026

977 people reported to have side effects when taking Vocabria.
Among them, 66 people (6.76%) have Rashes.

Among these 66 people:

How long have people been on Vocabria when they have Rashes? *

What is the gender of people who have Rashes when taking Vocabria? *

female: 28.89 %
male: 71.11 %

What is the age of people who have Rashes when taking Vocabria? *

What are other drugs people take besides Vocabria? *

What are other side effects people have besides Rashes? *

Swelling Face: 10 people, 15.15%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 9 people, 13.64%
Lip Swelling: 7 people, 10.61%
Itching: 7 people, 10.61%
Paraesthesia Oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect): 7 people, 10.61%
Dyspnea (difficult or laboured breathing): 7 people, 10.61%
Urticaria (rash of round, red welts on the skin that itch intensely): 5 people, 7.58%
Nausea (feeling of having an urge to vomit): 5 people, 7.58%
Throat Tightness: 5 people, 7.58%
Drug Hypersensitivity: 5 people, 7.58%

What are the existing conditions these people have? *

Hiv Infection: 25 people, 37.88%
Depression: 4 people, 6.06%
Back Pain: 3 people, 4.55%
Rash Macular (small, flat red spots): 2 people, 3.03%
Oedema (fluid collection in tissue): 2 people, 3.03%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 2 people, 3.03%
Mouth Ulcers: 2 people, 3.03%
Chills (felling of cold): 2 people, 3.03%
Injection Site Reaction: 1 person, 1.52%
Gastritis (inflammation of stomach): 1 person, 1.52%

* Approximation only. Some reports may have incomplete information.

Do you take Vocabria and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vocabria:

Vocabria (977 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Vocabria:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,712 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,212 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cabotegravir sodium (the active ingredients of Vocabria) and Vocabria (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.